Abstract
Abstract Background Minimal change disease (MCD) is a common pathological type of nephrotic syndrome in children and adults, and the mechanisms remain obscure. The diagnosis of MCD still relies on renal biopsy, lacking effective biological markers. This study explores the diagnostic value of circulating anti-nephrin antibody in MCD patients and evaluates the correlation with disease activity indicators such as proteinuria. Methods The study included 108 adult patients with glomerular disease, including 36 with MCD, 16 with primary focal segmental glomerulosclerosis (FSGS), 20 with primary membranous nephropathy (PMN), 17 with diabetic nephropathy (DN) and 19 with IgA nephropathy (IgAN). 20 healthy volunteers were included. Circulating anti-nephrin antibody was detected by indirect immunofluorescence method of cell-based assay (CBA). The ROC curve was used to evaluate the role of circulating anti-nephrin antibody in the diagnosis of MCD. The correlations between anti-nephrin antibody and clinical parameters were analyzed. Results The prevalence of circulating anti-nephrin antibody was 19.44% (7 of 36) in MCD, and 26.92% (7 of 26) in MCD patients with nephrotic proteinuria, which were higher than FSGS, PMN, DN, IgAN and healthy volunteer. The ROC curve showed that the sensitivity of anti-nephrin antibody used in the diagnosis of MCD was 19.4% and the specificity was 97.8%. The MCD patients with positive anti-nephrin antibody had heavier proteinuria, higher serum lipid levels, while lower serum albumin and blood IgG levels. Anti-nephrin antibody might turn to negative when the MCD patient had response to therapy. Conclusions Circulating anti-nephrin antibody may be a potential biomarker of MCD and may play a role in the MCD diagnosis.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call